Markets:

Overview

News

Currencies

International

Treasuries

iShares Russell 2000 ETF (NY:IWM)

251.42 -1.29 (-0.51%)

Official Closing Price Updated: 8:00 PM EST, Dec 26, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about iShares Russell 2000 ETF

< Previous 1 2

...

24 25 26 27 28 29 30 31 32

...

99 100 Next >

IonQ Announces Mixed Q4 Results, $500M At-the-Market Stock Offering - Stock Slips But Retail Support Stays Strong ↗

February 27, 2025

New bookings totaled $22.7 million for the fourth quarter and $95.6 million for the full year, exceeding the guidance of $75 million to $95 million.

Via Stocktwits

Bloomin’ Brands Stock Dives To One-Year Low After Q4 Revenue Fall: Retail Sentiment Turns Gloomy ↗

February 27, 2025

Sentiment on Stocktwits turned ‘bearish’ compared to ‘bullish’ a week ago

Via Stocktwits

Crucial Fibonacci Level ↗

February 27, 2025

In this article, we shall review the latest chart of Russell 2000/RTY Futures.

Via Talk Markets

Topics Stocks / Equities

MannKind Stock Surges After-Hours On Q4 Revenue Beat, Debt Reduction As Retail Investors Celebrate ‘Amazing Comeback’ ↗

February 27, 2025

The company significantly reduced its debt principal by $236 million, leaving just $36 million in remaining convertible debt, and ended 2024 with $203 million in cash, cash equivalents, and...

Via Stocktwits

Nasdaq And Russell 2000 Test January Support And Go "Meh" ↗

February 26, 2025

Not a whole lot of positivity to today, even though support held.

Via Talk Markets

Topics Stocks / Equities

Nvidia Earnings On Deck, SMCI Regains Compliance: What's Driving Markets Wednesday? ↗

February 26, 2025

All three major indices were green in midday trading Wednesday as the S&P 500 and Nasdaq 100 looked to snap their four-day losing streaks. NVIDIA Corp.

Via Benzinga

Golden Ocean CEO Says Company Using Current Market Weakness To Upgrade Fleet: Retail Sentiment Hits Year-High After Q4 Beat ↗

February 26, 2025

Revenue declined 17% year-over-year to $210.97 million but topped an analyst projection of $176.64 million.

Via Stocktwits

Cava Group's FY25 Guidance Is 'Very Achievable,' Says Gary Black Despite Mixed Q4: 'Economic Model Is Powerful,' Says CFO ↗

February 26, 2025

Restaurant chain owner CAVA Group reported a mixed fourth quarter and issued conservative guidance for the next fiscal year.

Via Benzinga

Arcutis Biotherapeutics Sees 400% Spike In Retail Buzz As Q4 Beat Fuels After-Hours Rally ↗

February 26, 2025

Sales of Zoryve, Arcutis' leading dermatology drug, surged 413% year-over-year to $69.4 million, a 55% increase from the previous quarter.

Via Stocktwits

Bitcoin Plunges As Consumer Confidence Falls: What's Driving Markets Tuesday? ↗

February 25, 2025

Markets fell broadly Tuesday with the S&P 500 trading at five-week lows and the Nasdaq extending its three-day losing streak. The Dow Jones managed to recover midday while Wall Street digested a...

Via Benzinga

Topics Stocks

What Has The Market Accomplished? ↗

February 25, 2025

Equities have taken a series of body blows in the three trading days since Wednesday’s high, the S&P 500 looked likely to make it to the end of the day yesterday and hold above its 50-day moving...

Via Talk Markets

Topics ETFs Stocks

Summit Therapeutics’ Retail Chatter Explodes As Pfizer Trial Pact Drowns Out Q4 Letdown ↗

February 24, 2025

Message volume on Stocktwits jumped 2,500%, with retail traders focusing on Summit’s partnership to evaluate ivonescimab in combination with Pfizer’s antibody-drug conjugates for solid tumors.

Via Stocktwits

You Win Some - You Lose Lots ↗

February 24, 2025

The S&P had started to clear resistance, posting new all-time highs before sellers struck with avengence.

Via Talk Markets

Topics Stocks Stocks / Equities

Palantir Extends Losses, Microsoft Slides: What's Driving Markets Monday? ↗

February 24, 2025

The major indices struggled to maintain early momentum on Monday, but appear to climbing back with the S&P 500 and Dow Jones both green in midday trading.

Via Benzinga

Topics Stocks

Volatility Playbook: Key Levels And Market Catalysts To Watch Now ↗

February 24, 2025

Markets are at a crossroads as small caps hit key support and tech shows signs of exhaustion.

Via Talk Markets

Topics Stocks / Equities

UK's Cineworld Reportedly Eyes IPO Or Merger With AMC Or Cinemark: Retail Isn't Biting Yet ↗

February 24, 2025

Cineworld emerged from Chapter 11 bankruptcy in mid-2023, nearly 11 months after filing for it.

Via Stocktwits

Topics Bankruptcy Initial Public Offering

Storm Clouds And Lightning Strikes Are Rolling In Over U.S. Stocks ↗

February 23, 2025

Nasdaq and S&P briefly hit new all-time highs before a dramatic reversal on Thursday and Friday which could be pointing to a failed breakout and double-top.

Via Talk Markets

Topics ETFs Stocks Stocks / Equities

The Inside Sectors Of The Economy Flash Warning ↗

February 23, 2025

Zooming out to the weekly chart of TLT, we see a double bottom in play from the lows in October 2023 and January 2025.

Via Talk Markets

Topics Commodities ETFs Economy

CoT: Peek Into The Future Thru Futures - How Hedge Funds Are Positioned, Feb. 23 ↗

February 23, 2025

It is tough guessing how things will shake out in the next few weeks, let alone for the remainder of the year or the next four years. If there is any certainty, it is that it will be volatile.

Via Talk Markets

Topics Stocks / Equities

S&P 500 Goes To Red... But.. ↗

February 21, 2025

I’m sending this to you because the S&P 500 ETF (SPY) has moved under its 20-day moving average and outflows have accelerated on the Russell 2000 and the S&P 500.

Via Talk Markets

Topics ETFs Stocks Stocks / Equities

Stock Market Indices Suffer Significant Trend Change Following Friday's Session ↗

February 21, 2025

In this video, I review the market warnings I've shared over the past three weeks and how Friday's session confirmed negative divergences across key metrics signaling weakness.

Via Talk Markets

Topics ETFs Stocks / Equities

Don't Call It A Stock Market Crash ↗

February 21, 2025

A look at what today's price action means from a technical analysis standpoint, and what you can do to be prepared for whatever the stock market throws your way.

Via Talk Markets

Topics ETFs Stocks / Equities

CarGurus Stock Slides After Mixed Q4 Results, Weak Guidance: Retail Mood Worsens ↗

February 21, 2025

Among key performance indicators, total paying dealers increased by 3%, and Quarterly Average Revenue per Subscribing Dealer (QARSD) gained 12% to $6,144.

Via Stocktwits

Ardelyx Stock Rises After-Hours On Q4 Beat, Drug Sales Outlook: Retail Gets Big Dose Of Optimism ↗

February 20, 2025

Revenue for the quarter was $116.13 million, topping the consensus estimate of $111.16 million, driven by robust sales of its two approved drugs, Ibsrela and Xphozah.

Via Stocktwits

Financial Markets Report For Thursday, Feb 20 ↗

February 20, 2025

In this video, Ira Epstein reviews the activity in the Financial Markets after the day that just ended, Thursday, February 20.

Via Talk Markets

Topics Commodities Cryptocurrencies Currencies/Forex

Russell 2000 Earnings Dashboard 24Q4 - Thuersday, Feb. 20 ↗

February 20, 2025

The 24Q4 Y/Y blended earnings growth estimate is 51.5%. If the energy sector is excluded, the growth rate for the index is 81.9%.

Via Talk Markets

Topics Stocks / Equities

S&P 500 Vs. Russell 2000: Are Small Caps Set For A Breakout? ↗

February 20, 2025

JPMorgan analyst notes S&P 500's struggle to break past 6,100 peak. Big caps hold ground, but small caps eyeing breakout. Investors should watch key levels and global cyclical trends for implications.

Via Benzinga

Topics Stocks

Palantir Rally Loses Steam, Walmart Outlook Disappoints: What's Driving Markets Thursday? ↗

February 20, 2025

Stocks tumbled Thursday, with all major indices in the red, one day after the S&P 500 notched another all-time high in Wednesday’s trading session.

Via Benzinga

Fidelis Insurance Stock Headed Toward Worst Single-Day Decline After Disclosing Aviation Litigation, California Wildfires Impact ↗

February 20, 2025

During Q4, the company incurred a net adverse prior-year development of $287.2 million attributable to its Aviation and Aerospace line of business.

Via Stocktwits

Candel Therapeutics Stock Rallies On Canaccord’s Vote Of Confidence In Lead Cancer Drug: Retail Traders Rejoice ↗

February 20, 2025

CAN-2409 could become a “best-in-class therapy” for borderline resectable pancreatic ductal adenocarcinoma, according to the analyst.

Via Stocktwits

< Previous 1 2

...

24 25 26 27 28 29 30 31 32

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.